Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2 (original) (raw)
Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers
Erik Lundgren
Journal of virology, 1994
View PDFchevron_right
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes
Eva Klein
Biochemical and Biophysical Research Communications, 2010
View PDFchevron_right
Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines
Ratakorn Srisuttee
Biomedical Reports, 2020
View PDFchevron_right
Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells
Michele Bernasconi
Journal of General Virology, 2007
View PDFchevron_right
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23
Clare Sample
Journal of Virology, 1990
View PDFchevron_right
Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures
Gosta Winberg
European Journal of Immunology, 1990
View PDFchevron_right
Epstein-Barr virus and the B cell: that's all it takes
Gulfaraz Khan
Trends in Microbiology, 1996
View PDFchevron_right
A Subpopulation of Normal B Cells Latently Infected with Epstein-Barr Virus Resembles Burkitt Lymphoma Cells in Expressing EBNA-1 but Not EBNA-2 or LMP1
L. Hu, Gosta Winberg
1995
View PDFchevron_right
The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection
Aki Hoji
PLoS ONE, 2013
View PDFchevron_right
Monoclonal Antibodies to the Latent Membrane Protein of Epstein-Barr Virus Reveal Heterogeneity of the Protein and Inducible Expression in Virus-transformed Cells
Elliott Kieff
Journal of General Virology, 1987
View PDFchevron_right
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus
ezgi akidil
mBio
View PDFchevron_right
The epstein-barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in burkitt lymphoma lines
Alberto Rodriguez-archilla
International Journal of Cancer, 1994
View PDFchevron_right
Identification of the Epstein-Barr Virus Terminal Protein Gene products in latently infected lymphocytes
Laurence S Dawkins-Hall B.Sc (Hons), (Reg), CBiol, CSci, FIScT, FRSB,
Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes. , 1990
View PDFchevron_right
Expression of the Epstein–Barr virus latent membrane protein 1 induces B cell …
Friedrich Grässer
Proceedings of the …
View PDFchevron_right
Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth
S. Tobollik
Blood, 2006
View PDFchevron_right
Short Communication Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells
Michele Bernasconi
2000
View PDFchevron_right
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
Jaap Middeldorp
Critical Reviews in Oncology/Hematology, 2003
View PDFchevron_right
Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation
Bill Sugden
Journal of Virology, 1993
View PDFchevron_right
Antagonistic effects ofc-myc and Epstein-Barr virus latent genes on the phenotype of human B cells
Axel Polack
International Journal of Cancer, 2001
View PDFchevron_right
Restricted Epstein-Barr-Virus Protein Expression in Burkitt-Lymphoma is Due to a Different Epstein-Barr Nuclear ANTIGEN-1 Transcriptional Initiation Site
Clare Sample
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991
View PDFchevron_right
The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels
Wolfgang Hammerschmidt
Journal of Virology, 1989
View PDFchevron_right
The first days in the life of naïve human B-lymphocytes infected with Epstein-Barr virus
ezgi akidil
View PDFchevron_right
T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus- carrying Burkitt lymphoma lines
Jun Nishikawa
Proceedings of the National Academy of Sciences, 2003
View PDFchevron_right
Epstein-Barr virus oncogenesis
H. Knecht
Critical Reviews in Oncology/Hematology, 1997
View PDFchevron_right
Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude mice
Mette Munch
Molecular Pathology, 1996
View PDFchevron_right
B Cell Phenotype-dependent Expression of the Epstein-Barr Virus Nuclear Antigens EBNA-2 to EBNA-6: Studies with Somatic Cell Hybrids
Ender Altıok
Journal of General Virology, 1991
View PDFchevron_right
Cellular factors associated with latency and spontaneous Epstein–Barr virus reactivation in B-lymphoblastoid cell lines
David Lynch, James Lyons-Weiler
Virology, 2010
View PDFchevron_right
Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines
Mark Birkenbach
Journal of Virology
View PDFchevron_right
The Epstein-Barr Virus Regulome in Lymphoblastoid Cells
Hufeng Zhou
Cell host & microbe, 2017
View PDFchevron_right
Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma
Gulfaraz Khan
British Journal of Haematology, 2005
View PDFchevron_right
Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells
Pankaj Kumar
PLoS ONE, 2009
View PDFchevron_right
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
cj mancao
Blood, 2007
View PDFchevron_right
Control of Cell Cycle Entry and Apoptosis in B Lymphocytes Infected by Epstein-Barr Virus
Lindsay Spender
Journal of Virology, 1999
View PDFchevron_right
Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis
Klaus Rajewsky
Proceedings of the National Academy of Sciences, 2020
View PDFchevron_right